TDOC Teladoc Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: TDOC

Price (delayed)

$6.96

Market cap

$1.26B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.99

Enterprise value

$1.52B

?
Relative Growth: Rel. Growth: 25
Relative Strength: Rel. Strength: 50
Relative Valuation: Rel. Valuation: 59
Relative Profitability: Rel. Profitability: 36

Teladoc Health is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst ...

Highlights
The company's EPS rose by 15% YoY but it fell by 2.1% QoQ
TDOC's net income is up by 14% year-on-year but it is down by 3.7% since the previous quarter
TDOC's quick ratio has dropped by 70% since the previous quarter and by 68% year-on-year
Teladoc Health's equity has decreased by 8% YoY
Sector: Healthcare
Industry: Health Information Services
Website: http://www.teladochealth.com
Peers: HCA BKD CYH

Key stats

What are the main financial stats of TDOC

TDOC stock price

How has the Teladoc Health stock price performed over time
Intraday
3.73%
1 week
4.19%
1 month
-27.88%
1 year
-6.45%
YTD
-0.57%
QTD
-17.92%

Financial performance

How have Teladoc Health's revenue and profit performed over time
Revenue
$2.49B
Gross profit
$1.72B
Operating income
-$186.82M
Net income
-$177.4M
Gross margin
69%
Net margin
-7.1%
TDOC's operating income is up by 30% YoY and by 8% from the previous quarter
The operating margin has grown by 29% YoY and by 7% from the previous quarter
TDOC's net income is up by 14% year-on-year but it is down by 3.7% since the previous quarter
TDOC's net margin is up by 13% YoY but it is down by 4.4% from the previous quarter

Price vs fundamentals

How does TDOC's price correlate with its fundamentals

Growth

What is Teladoc Health's growth rate over time

Valuation

What is Teladoc Health stock price valuation
P/E
N/A
P/B
0.96
P/S
0.51
EV/EBIT
N/A
EV/EBITDA
7.04
EV/Sales
0.61
The company's EPS rose by 15% YoY but it fell by 2.1% QoQ
The stock's price to book (P/B) is 20% less than its 5-year quarterly average of 1.2 but 7% more than its last 4 quarters average of 0.9
Teladoc Health's equity has decreased by 8% YoY
The P/S is 76% below the 5-year quarterly average of 2.1 but 2% above the last 4 quarters average of 0.5
TDOC's revenue is down by 2.1% year-on-year

Efficiency

How efficient is Teladoc Health business performance
Teladoc Health's return on invested capital has decreased by 25% QoQ
The company's return on sales rose by 21% YoY
Teladoc Health's ROE has increased by 8% YoY but it has decreased by 6% from the previous quarter
TDOC's return on assets is down by 5% since the previous quarter

Dividends

What is TDOC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TDOC.

Financial health

How did Teladoc Health financials performed over time
Teladoc Health's total assets is 90% higher than its total liabilities
The current ratio has dropped by 70% since the previous quarter and by 69% year-on-year
TDOC's quick ratio has dropped by 70% since the previous quarter and by 68% year-on-year
TDOC's debt is 22% less than its equity
The debt to equity has grown by 8% YoY
Teladoc Health's equity has decreased by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.